| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |